サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1460208

ソフトミスト吸入器市場- 世界の産業分析、規模、シェア、成長、動向、予測、2023年～2031年

Soft Mist Inhalers Market [Type: Disposable and Reusable; Application: Asthma, COPD, and Others (Cystic Fibrosis, etc.); and Age Group: Adults and Pediatrics] - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日: | 発行: Transparency Market Research | ページ情報: 英文 120 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
ソフトミスト吸入器市場- 世界の産業分析、規模、シェア、成長、動向、予測、2023年～2031年
出版日: 2024年02月08日
発行: Transparency Market Research
ページ情報: 英文 120 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ソフトミスト吸入器市場- 調査範囲

TMR社の調査レポート「世界のソフトミスト吸入器市場」は、2023年から2031年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。レポートでは、2023年を基準年、2031年を予測年として、2017年から2031年までの世界のソフトミスト吸入器市場の収益と予測を提供します。また、2023年から2031年までの世界のソフトミスト吸入器市場の複合年間成長率（CAGR %）も掲載しています。

本レポートは広範な調査を経て作成されました。1次調査では、アナリストが主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。2次調査では、ソフトミスト吸入器市場を理解するために、主要企業の製品資料、年次報告書、プレスリリース、関連文書などを参照しました。

市場スナップショット
2022年の市場価値 24億米ドル
2031年の市場価値 44億米ドル
CAGR 6.8%

本レポートでは、世界のソフトミスト吸入器市場の競合情勢について掘り下げています。世界のソフトミスト吸入器市場で活動する主要企業が特定され、これらの各企業が様々な属性でプロファイリングされています。企業概要、財務状況、最近の市場開拓、SWOTは、本レポートで紹介されている世界のソフトミスト吸入器市場における企業の属性です。

目次

第1章 序文

第2章 調査前提条件と調査手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

  • イントロダクション
  • 市場概要
  • 市場力学
  • 世界市場の分析と予測、2017年～2031年

第5章 主要洞察

  • パイプライン分析
  • 地域/世界別の規制シナリオ
  • 疾患有病率および罹患率と主要国との世界比較
  • COVID-19インパクト分析

第6章 世界市場分析と予測：タイプ別

  • イントロダクションと定義
  • 主な調査結果/発展
  • タイプ別市場金額予測、2017年～2031年
    • 使い捨て
    • 再利用可能
  • タイプ別市場魅力度

第7章 世界市場分析と予測：年齢層別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 年齢層別市場金額予測、2017年～2031年
    • 成人
    • 小児
  • 年齢層別市場魅力度

第8章 世界市場分析・予測：用途別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 用途別市場金額予測、2017年～2031年
    • 喘息
    • COPD（慢性閉塞性肺疾患）
    • その他（嚢胞性線維症など）
  • 用途別市場魅力度

第9章 世界市場分析・予測：エンドユーザー別

  • イントロダクションと定義
  • 主な調査結果/発展
  • エンドユーザー別市場金額予測、2017年～2031年
    • 病院
    • 診療所
    • その他（在宅ケアなど）
  • エンドユーザー別市場魅力度

第10章 世界市場分析・予測：地域別

  • 主な調査結果
  • 地域別市場金額予測
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 国・地域別市場魅力度

第11章 北米市場の分析と予測

  • 米国
  • カナダ

第12章 欧州市場の分析と予測

  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州

第13章 アジア太平洋市場の分析と予測

  • 中国
  • インド
  • 日本
  • オーストラリア・ニュージーランド
  • その他アジア太平洋

第14章 ラテンアメリカ市場の分析と予測

  • ブラジル
  • メキシコ
  • その他のラテンアメリカ

第15章 中東・アフリカ市場の分析と予測

  • GCC諸国
  • 南アフリカ
  • その他の中東・アフリカ

第16章 競合情勢

  • 市場競合- 競争マトリックス（階層別、企業規模別）
  • 企業プロファイル
    • レシファーム
    • ベーリンガーインゲルハイム
    • メルキシン社
    • DSBメディカル
    • レシカBV
    • エアロポンプGmbH
    • ウルザテックGmbH

第17章 競合情勢

  • 市場競合- 競争マトリックス（ティア別、企業規模別）
  • 企業シェア分析（2022年）
  • 企業プロファイル
    • Recipharm
    • Boehringer Ingelheim
    • Merxin Ltd.
    • DSB Medical Co., Ltd.
    • Resyca BV
    • Aero Pump GmbH
    • Ursatec GmbH
図表

List of Tables

  • Table 01: Global Soft Mist Inhalers Market Value (US$ Mn) Forecast, by Age Group, 2017-2031
  • Table 02: Global Soft Mist Inhalers Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 03: Global Soft Mist Inhalers Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 04: Global Soft Mist Inhalers Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 05: Global Soft Mist Inhalers Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 06: North America Soft Mist Inhalers Market Value (US$ Mn) Forecast, by Age Group, 2017-2031
  • Table 07: North America Soft Mist Inhalers Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 08: North America Soft Mist Inhalers Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 09: North America Soft Mist Inhalers Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 10: North America Soft Mist Inhalers Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 11: Europe Soft Mist Inhalers Market Value (US$ Mn) Forecast, by Age Group, 2017-2031
  • Table 12: Europe Soft Mist Inhalers Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 13: Europe Soft Mist Inhalers Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 14: Europe Soft Mist Inhalers Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 15: Europe Soft Mist Inhalers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 16: Asia Pacific Soft Mist Inhalers Market Value (US$ Mn) Forecast, by Age Group, 2017-2031
  • Table 17: Asia Pacific Soft Mist Inhalers Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 18: Asia Pacific Soft Mist Inhalers Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 19: Asia Pacific Soft Mist Inhalers Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 20: Latin America Soft Mist Inhalers Market Value (US$ Mn) Forecast, by Age Group, 2017-2031
  • Table 21: Latin America Soft Mist Inhalers Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 22: Latin America Soft Mist Inhalers Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 23: Latin America Soft Mist Inhalers Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 24: Latin America Soft Mist Inhalers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 25: Middle East & Africa Soft Mist Inhalers Market Value (US$ Mn) Forecast, by Age Group, 2017-2031
  • Table 26: Middle East & Africa Soft Mist Inhalers Market Value (US$ Mn) Forecast, by Type, 2017-2031
  • Table 27: Middle East & Africa Soft Mist Inhalers Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 28: Middle East & Africa Soft Mist Inhalers Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 29: Middle East & Africa Soft Mist Inhalers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

List of Figures

  • Figure 01: Global Soft Mist Inhalers Market Size (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Soft Mist Inhalers Market Value Share, by Type (2022)
  • Figure 03: Global Soft Mist Inhalers Market Value Share, by Age Group (2022)
  • Figure 04: Global Soft Mist Inhalers Market Value Share, by Application (2022)
  • Figure 05: Global Soft Mist Inhalers Market Value Share, by End-user (2022)
  • Figure 06: Global Soft Mist Inhalers Market Value Share, by Region (2022)
  • Figure 07: Global Soft Mist Inhalers Market Value Share, by Age Group, 2022-2031
  • Figure 08 Global Soft Mist Inhalers Market Attractiveness Analysis, by Age Group, 2017-2031
  • Figure 09: Global Soft Mist Inhalers Market Value Share, by Type, 2022-2031
  • Figure 10: Global Soft Mist Inhalers Market Attractiveness Analysis, by Type, 2017-2031
  • Figure 11: Global Soft Mist Inhalers Market Value Share, by Application, 2022-2031
  • Figure 12: Global Soft Mist Inhalers Market Attractiveness Analysis, by Application, 2017-2031
  • Figure 13: Global Soft Mist Inhalers Market Value Share, by End-user, 2022-2031
  • Figure 14: Global Soft Mist Inhalers Market Attractiveness Analysis, by End-user, 2017-2031
  • Figure 15: Global Soft Mist Inhalers Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017-2031
  • Figure 16: Global Soft Mist Inhalers Market Value Share, by Region, 2017-2031
  • Figure 17: Global Soft Mist Inhalers Market Attractiveness Analysis, by Region, 2017-2031
  • Figure 18: North America Soft Mist Inhalers Market Value Share, by Age Group, 2022-2031
  • Figure 19: North America Soft Mist Inhalers Market Attractiveness Analysis, by Age Group, 2017-2031
  • Figure 20: North America Soft Mist Inhalers Market Value Share, by Type, 2022-2031
  • Figure 21: North America Soft Mist Inhalers Market Attractiveness Analysis, by Type, 2017-2031
  • Figure 22: North America Soft Mist Inhalers Market Value Share, by Application, 2022-2031
  • Figure 23: North America Soft Mist Inhalers Market Attractiveness Analysis, by Application, 2017-2031
  • Figure 24: North America Soft Mist Inhalers Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017-2031
  • Figure 25: North America Soft Mist Inhalers Market Attractiveness Analysis, by End-user, 2017-2031
  • Figure 26: North America Soft Mist Inhalers Market Value Share, by Country, 2017-2031
  • Figure 27: North America Soft Mist Inhalers Market Attractiveness Analysis, by Country, 2017-2031
  • Figure 28: Europe Soft Mist Inhalers Market Value Share, by Age Group, 2022-2031
  • Figure 29: Europe Soft Mist Inhalers Market Attractiveness Analysis, by Age Group, 2017-2031
  • Figure 30: Europe Soft Mist Inhalers Market Value Share, by Type, 2022-2031
  • Figure 31: Europe Soft Mist Inhalers Market Attractiveness Analysis, by Type, 2017-2031
  • Figure 32: Europe Soft Mist Inhalers Market Value Share, by Application, 2022-2031
  • Figure 33: Europe Soft Mist Inhalers Market Attractiveness Analysis, by Application, 2017-2031
  • Figure 34: Europe Soft Mist Inhalers Market Value Share, by End-user, 2022-2031
  • Figure 35: Europe Soft Mist Inhalers Market Attractiveness Analysis, by End-user, 2017-2031
  • Figure 36: Europe Soft Mist Inhalers Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017-2031
  • Figure 37: Europe Soft Mist Inhalers Market Value Share, by Country/Sub-region, 2017-2031
  • Figure 38: Europe Soft Mist Inhalers Market Attractiveness Analysis, by Country/Sub-region, 2017-2031
  • Figure 39: Asia Pacific Soft Mist Inhalers Market Value Share, by Age Group, 2022-2031
  • Figure 40: Asia Pacific Soft Mist Inhalers Market Attractiveness Analysis, by Age Group, 2017-2031
  • Figure 41: Asia Pacific Soft Mist Inhalers Market Value Share, by Type, 2022-2031
  • Figure 42: Asia Pacific Soft Mist Inhalers Market Attractiveness Analysis, by Type, 2017-2031
  • Figure 43: Asia Pacific Soft Mist Inhalers Market Value Share, by Application, 2022-2031
  • Figure 44: Asia Pacific Soft Mist Inhalers Market Attractiveness Analysis, by Application, 2017-2031
  • Figure 45: Asia Pacific Soft Mist Inhalers Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017-2031
  • Figure 46: Asia Pacific Soft Mist Inhalers Market Value Share, by End-user, 2022-2031
  • Figure 47: Asia Pacific Soft Mist Inhalers Market Attractiveness Analysis, by End-user, 2017-2031
  • Figure 48: Asia Pacific Soft Mist Inhalers Market Value Share, by Country/Sub-region, 2017-2031
  • Figure 49: Asia Pacific Soft Mist Inhalers Market Attractiveness Analysis, by Country/Sub-region, 2017-2031
  • Figure 50: Latin America Soft Mist Inhalers Market Value Share, by Age Group, 2022-2031
  • Figure 51: Latin America Soft Mist Inhalers Market Attractiveness Analysis, by Age Group, 2017-2031
  • Figure 52: Latin America Soft Mist Inhalers Market Value Share, by Type, 2022-2031
  • Figure 53: Latin America Soft Mist Inhalers Market Attractiveness Analysis, by Type, 2017-2031
  • Figure 54: Latin America Soft Mist Inhalers Market Value Share, by Application, 2022-2031
  • Figure 55: Latin America Soft Mist Inhalers Market Attractiveness Analysis, by Application, 2017-2031
  • Figure 56: Latin America Soft Mist Inhalers Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017-2031
  • Figure 57: Latin America Soft Mist Inhalers Market Value Share, by End-user, 2022-2031
  • Figure 58: Latin America Soft Mist Inhalers Market Attractiveness Analysis, by End-user, 2017-2031
  • Figure 59: Latin America Soft Mist Inhalers Market Value Share, by Country/Sub-region, 2017-2031
  • Figure 60: Latin America Soft Mist Inhalers Market Attractiveness Analysis, by Country/Sub-region, 2017-2031
  • Figure 61: Middle East & Africa Soft Mist Inhalers Market Value Share, by Age Group, 2022-2031
  • Figure 62: Middle East & Africa Soft Mist Inhalers Market Attractiveness Analysis, by Age Group, 2017-2031
  • Figure 63: Middle East & Africa Soft Mist Inhalers Market Value Share, by Type, 2022-2031
  • Figure 64: Middle East & Africa Soft Mist Inhalers Market Attractiveness Analysis, by Type, 2017-2031
  • Figure 65: Middle East & Africa Soft Mist Inhalers Market Value Share, by Application, 2022-2031
  • Figure 66: Middle East & Africa Soft Mist Inhalers Market Attractiveness Analysis, by Application, 2017-2031
  • Figure 67: Middle East & Africa Soft Mist Inhalers Market Value Share, by End-user, 2022-2031
  • Figure 68: Middle East & Africa Soft Mist Inhalers Market Attractiveness Analysis, by End-user, 2017-2031
  • Figure 69: Middle East & Africa Soft Mist Inhalers Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017-2031
  • Figure 70: Middle East & Africa Soft Mist Inhalers Market Value Share, by Country/Sub-region, 2017-2031
  • Figure 71: Middle East & Africa Soft Mist Inhalers Market Attractiveness Analysis, by Country/Sub-region, 2017-2031
目次
Product Code: TMRGL85947

Soft Mist Inhalers Market - Scope of Report

TMR's report on the global soft mist inhalers market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global soft mist inhalers market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global soft mist inhalers market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the soft mist inhalers market.

Market Snapshot
Market Value in 2022US$ 2.4 Bn
Market Value in 2031US$ 4.4 Bn
CAGR6.8%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global soft mist inhalers market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global soft mist inhalers market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global soft mist inhalers market.

The report delves into the competitive landscape of the global soft mist inhalers market. Key players operating in the global soft mist inhalers market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global soft mist inhalers market profiled in this report.

Key Questions Answered in Global soft mist inhalers Market Report:

  • What is the sales/revenue generated by soft mist inhalers across all regions during the forecast period?
  • What are the opportunities in the global soft mist inhalers market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Soft Mist Inhalers Market - Research Objectives and Research Approach

The comprehensive report on the global soft mist inhalers market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global soft mist inhalers market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global soft mist inhalers market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Soft Mist Inhalers Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Type Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Soft Mist Inhalers Market Analysis and Forecasts, 2017-2031

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Regulatory Scenario by Region/Globally
  • 5.3. Disease Prevalence & Incidence Rate Globally with Key Countries
  • 5.4. COVID-19 Impact Analysis

6. Global Soft Mist Inhalers Market Analysis and Forecasts, By Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Type, 2017-2031
    • 6.3.1. Disposable
    • 6.3.2. Reusable
  • 6.4. Market Attractiveness By Type

7. Global Soft Mist Inhalers Market Analysis and Forecasts, By Age Group

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Age Group, 2017-2031
    • 7.3.1. Adults
    • 7.3.2. Pediatrics
  • 7.4. Market Attractiveness By Age Group

8. Global Soft Mist Inhalers Market Analysis and Forecasts, By Application

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By Application, 2017-2031
    • 8.3.1. Asthma
    • 8.3.2. COPD
    • 8.3.3. Others (Cystic Fibrosis, etc.)
  • 8.4. Market Attractiveness By Application

9. Global Soft Mist Inhalers Market Analysis and Forecasts, By End-user

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast By End-user, 2017-2031
    • 9.3.1. Hospitals
    • 9.3.2. Clinics
    • 9.3.3. Others (Home Care, etc.)
  • 9.4. Market Attractiveness By End-user

10. Global Soft Mist Inhalers Market Analysis and Forecasts, By Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast By Region
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness By Country/Region

11. North America Soft Mist Inhalers Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Type, 2017-2031
    • 11.2.1. Disposable
    • 11.2.2. Reusable
  • 11.3. Market Value Forecast By Age Group, 2017-2031
    • 11.3.1. Adults
    • 11.3.2. Pediatrics
  • 11.4. Market Value Forecast By Application, 2017-2031
    • 11.4.1. Asthma
    • 11.4.2. COPD
    • 11.4.3. Others (Cystic Fibrosis, etc.)
  • 11.5. Market Value Forecast By End-user, 2017-2031
    • 11.5.1. Hospitals
    • 11.5.2. Clinics
    • 11.5.3. Others (Home Care, etc.)
  • 11.6. Market Value Forecast By Country, 2017-2031
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Type
    • 11.7.2. By Age Group
    • 11.7.3. By Application
    • 11.7.4. By End-user
    • 11.7.5. By Country

12. Europe Soft Mist Inhalers Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Type, 2017-2031
    • 12.2.1. Disposable
    • 12.2.2. Reusable
  • 12.3. Market Value Forecast By Age Group, 2017-2031
    • 12.3.1. Adults
    • 12.3.2. Pediatrics
  • 12.4. Market Value Forecast By Application, 2017-2031
    • 12.4.1. Asthma
    • 12.4.2. COPD
    • 12.4.3. Others (Cystic Fibrosis, etc.)
  • 12.5. Market Value Forecast By End-user, 2017-2031
    • 12.5.1. Hospitals
    • 12.5.2. Clinics
    • 12.5.3. Others (Home Care, etc.)
  • 12.6. Market Value Forecast By Country, 2017-2031
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Italy
    • 12.6.5. Spain
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Type
    • 12.7.2. By Age Group
    • 12.7.3. By Application
    • 12.7.4. By End-user
    • 12.7.5. By Country

13. Asia Pacific Soft Mist Inhalers Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Type, 2017-2031
    • 13.2.1. Disposable
    • 13.2.2. Reusable
  • 13.3. Market Value Forecast By Age Group, 2017-2031
    • 13.3.1. Adults
    • 13.3.2. Pediatrics
  • 13.4. Market Value Forecast By Application, 2017-2031
    • 13.4.1. Asthma
    • 13.4.2. COPD
    • 13.4.3. Others (Cystic Fibrosis, etc.)
  • 13.5. Market Value Forecast By End-user, 2017-2031
    • 13.5.1. Hospitals
    • 13.5.2. Clinics
    • 13.5.3. Others (Home Care, etc.)
  • 13.6. Market Value Forecast By Country, 2017-2031
    • 13.6.1. China
    • 13.6.2. India
    • 13.6.3. Japan
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Type
    • 13.7.2. By Age Group
    • 13.7.3. By Application
    • 13.7.4. By End-user
    • 13.7.5. By Country

14. Latin America Soft Mist Inhalers Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Type, 2017-2031
    • 14.2.1. Disposable
    • 14.2.2. Reusable
  • 14.3. Market Value Forecast By Age Group, 2017-2031
    • 14.3.1. Adults
    • 14.3.2. Pediatrics
  • 14.4. Market Value Forecast By Application, 2017-2031
    • 14.4.1. Asthma
    • 14.4.2. COPD
    • 14.4.3. Others (Cystic Fibrosis, etc.)
  • 14.5. Market Value Forecast By End-user, 2017-2031
    • 14.5.1. Hospitals
    • 14.5.2. Clinics
    • 14.5.3. Others (Home Care, etc.)
  • 14.6. Market Value Forecast By Country, 2017-2031
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Type
    • 14.7.2. By Age Group
    • 14.7.3. By Application
    • 14.7.4. By End-user
    • 14.7.5. By Country

15. Middle East & Africa Soft Mist Inhalers Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast By Type, 2017-2031
    • 15.2.1. Disposable
    • 15.2.2. Reusable
  • 15.3. Market Value Forecast By Age Group, 2017-2031
    • 15.3.1. Adults
    • 15.3.2. Pediatrics
  • 15.4. Market Value Forecast By Application, 2017-2031
    • 15.4.1. Asthma
    • 15.4.2. COPD
    • 15.4.3. Others (Cystic Fibrosis, etc.)
  • 15.5. Market Value Forecast By End-user, 2017-2031
    • 15.5.1. Hospitals
    • 15.5.2. Clinics
    • 15.5.3. Others (Home Care, etc.)
  • 15.6. Market Value Forecast By Country, 2017-2031
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Type
    • 15.7.2. By Age Group
    • 15.7.3. By Application
    • 15.7.4. By End-user
    • 15.7.5. By Country

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 16.2. Company Profiles
    • 16.2.1. Recipharm
    • 16.2.2. Boehringer Ingelheim
    • 16.2.3. Merxin Ltd
    • 16.2.4. DSB Medical Co., Ltd.
    • 16.2.5. Resyca BV
    • 16.2.6. Aero Pump GmbH
    • 16.2.7. Ursatec GmbH

17. Competition Landscape

  • 17.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 17.2. Market Share Analysis By Company (2022)
  • 17.3. Company Profiles
    • 17.3.1. Recipharm
      • 17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.1.2. Material Portfolio
      • 17.3.1.3. Financial Overview
      • 17.3.1.4. SWOT Analysis
      • 17.3.1.5. Strategic Overview
    • 17.3.2. Boehringer Ingelheim
      • 17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.2.2. Material Portfolio
      • 17.3.2.3. Financial Overview
      • 17.3.2.4. SWOT Analysis
      • 17.3.2.5. Strategic Overview
    • 17.3.3. Merxin Ltd.
      • 17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.3.2. Material Portfolio
      • 17.3.3.3. Financial Overview
      • 17.3.3.4. SWOT Analysis
      • 17.3.3.5. Strategic Overview
    • 17.3.4. DSB Medical Co., Ltd.
      • 17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.4.2. Material Portfolio
      • 17.3.4.3. Financial Overview
      • 17.3.4.4. SWOT Analysis
      • 17.3.4.5. Strategic Overview
    • 17.3.5. Resyca BV
      • 17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.5.2. Material Portfolio
      • 17.3.5.3. Financial Overview
      • 17.3.5.4. SWOT Analysis
      • 17.3.5.5. Strategic Overview
    • 17.3.6. Aero Pump GmbH
      • 17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.6.2. Material Portfolio
      • 17.3.6.3. Financial Overview
      • 17.3.6.4. SWOT Analysis
      • 17.3.6.5. Strategic Overview
    • 17.3.7. Ursatec GmbH
      • 17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.7.2. Material Portfolio
      • 17.3.7.3. Financial Overview
      • 17.3.7.4. SWOT Analysis
      • 17.3.7.5. Strategic Overview